LDI
loanDepot Inc. Class A
$2.59
+$0.18(+7.47%)
35
Overall
50
Value
20
Tech
--
Quality
Market Cap
$625.58M
Volume
2.59M
52W Range
$1.01 - $5.05
Target Price
$2.63
Company Overview
| Mkt Cap | $625.58M | Price | $2.59 |
| Volume | 2.59M | Change | +7.47% |
| P/E Ratio | -6.4 | Open | $2.43 |
| Revenue | $551.0M | Prev Close | $2.41 |
| Net Income | $-98.3M | 52W Range | $1.01 - $5.05 |
| Div Yield | N/A | Target | $2.63 |
| Overall | 35 | Value | 50 |
| Quality | -- | Technical | 20 |
No chart data available
About loanDepot Inc. Class A
loanDepot, Inc. engages in originating, financing, selling, and servicing residential mortgage loans in the United States. The company offers conventional agency-conforming and prime jumbo, federal assistance residential mortgage, and home equity lines of credit and closed-end second liens. It also provides settlement services, which include captive title and escrow business; real estate services that cover captive real estate referral business; and insurance services, including services to homeowners, as well as other consumer insurance policies. The company was founded in 2010 and is headquartered in Irvine, California.
Latest News
Calidi Biotherapeutics Unveils New Data on CLD-401
TipRanks Auto-Generated Newsdesk•13 days ago
loanDepot, Inc. Q3 Earnings Call: Strategic Gains Amid Challenges
TipRanks Auto-Generated Newsdesk•15 days ago
loanDepot Reports Q3 Revenue Growth and Reduced Loss
TipRanks Auto-Generated Newsdesk•17 days ago
Calidi Biotherapeutics Sells Majority Stake in Nova Cell
TipRanks Auto-Generated Newsdesk•23 days ago
Calidi Biotherapeutics Forms New Advisory Board
TipRanks Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LDI | $2.59 | +7.5% | 2.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |